EP1525878A1 - Composition for caries prevention - Google Patents
Composition for caries prevention Download PDFInfo
- Publication number
- EP1525878A1 EP1525878A1 EP04024388A EP04024388A EP1525878A1 EP 1525878 A1 EP1525878 A1 EP 1525878A1 EP 04024388 A EP04024388 A EP 04024388A EP 04024388 A EP04024388 A EP 04024388A EP 1525878 A1 EP1525878 A1 EP 1525878A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- cpp
- weight
- caries
- acp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 208000002925 dental caries Diseases 0.000 title claims abstract description 37
- 230000002265 prevention Effects 0.000 title abstract description 25
- 108010076119 Caseins Proteins 0.000 claims abstract description 25
- 239000005018 casein Substances 0.000 claims abstract description 25
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000021240 caseins Nutrition 0.000 claims abstract description 25
- 108010019954 casein phosphopeptide-amorphous calcium phosphate nanocomplex Proteins 0.000 claims abstract description 23
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 19
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 16
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 16
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 16
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 16
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 15
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 15
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 15
- 238000006266 etherification reaction Methods 0.000 claims abstract description 11
- GUYBGCBOZOALMT-UHFFFAOYSA-J dicalcium;fluoride;phosphate Chemical compound [F-].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O GUYBGCBOZOALMT-UHFFFAOYSA-J 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000000214 mouth Anatomy 0.000 claims description 15
- 229940091249 fluoride supplement Drugs 0.000 claims description 9
- -1 fluoride compound Chemical class 0.000 claims description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 6
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 3
- 239000011775 sodium fluoride Substances 0.000 claims description 3
- 235000013024 sodium fluoride Nutrition 0.000 claims description 3
- 229960000414 sodium fluoride Drugs 0.000 claims description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 3
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 3
- 229960002799 stannous fluoride Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 238000005115 demineralization Methods 0.000 abstract description 8
- 230000002328 demineralizing effect Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000003298 dental enamel Anatomy 0.000 description 14
- 238000002156 mixing Methods 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 208000008617 Tooth Demineralization Diseases 0.000 description 1
- 206010072665 Tooth demineralisation Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000004851 dental resin Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 235000019557 luminance Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to a composition for oral cavity to prevent a caries, which has effects for suppressing tooth demineralization and promoting tooth remineralization.
- CPP - ACP casein phosphopeptide - amorphous calcium phosphate complex
- the CPP - ACP is a material comprising a complex of peptide derived from milk protein (casein) and an inorganic material (an amorphous calcium phosphate) , and it has been said that the CPP - ACP act on demineralization and remineralization of the tooth since it contains calcium and phosphorus, which are inorganic components of the tooth, as the constituent elements (for example, refer to non-patent literature 1, Reynolds EC et al.
- the inhibition of demineralization action is based on the following logic, where the solubility of calcium phosphate in the enamel subsurface is remarkably decreased since the ion concentration in saliva on the enamel subsurface or the inside of a dental plaque is kept in the supersaturated state with the ions of calcium and phosphorus came from the CPP - ACP, and then, the tooth becomes to be hardly melted.
- CPP - ACFP casein phosphopeptide - amorphous calcium fluoride phosphate complex
- the foods such as a chewing gum and a candy
- the compositions for oral care such as a dentifrice and a mouth washing agent, which assist the caries prevention by containing the CPP - ACP and CPP - ACFP having the above action, have been disclosed (for example, refer to patent literature 1, published Japanese translation of PCT international publication for patent application 2002- 500626, and patent literature 2, published Japanese translation of PCT international publication for patent application 2002- 540129).
- the present invention has the object to provide the composition for the caries prevention, which has the effects for efficiently suppressing the demineralization and promoting the remineralization, and an excellent stability in keeping for a long time.
- the present inventors made wholeheartedly investigations in order to solve the above problems, and as the result, they found out the method to obtain the excellent composition for the caries prevention. That is, in the composition comprising (a) the casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP), (b) a sodium carboxymethylcellulose, (c) a viscosity regulator, and (d) water, when the sodium carboxymethylcellulose having a specific etherification degree was used, the composition for the caries prevention, which has the effects for efficiently suppressing the demineralization and promoting the remineralization, and the excellent stability in keeping for a long time, was obtained. Then, the present invention was completed.
- the composition for the caries prevention which has the effects for efficiently suppressing the demineralization and promoting the remineralization, and the excellent stability in keeping for a long time, was
- composition for the oral cavity to prevent the caries comprises (a) 1 to 30 % by weight of the casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP), (b) 0.01 to 10 % by weight of the sodium carboxymethylcellulose, having the etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of the viscosity regulator, and (d) a residual amount of water.
- This composition is used by coating on the tooth.
- a composition for oral cavity to prevent a caries comprises (a) 1 to 30 % by weight of the casein phosphopeptide-amorphous calcium phosphate complex (CCP-ACP) and/or the casein phosphopeptide-amorphous calcium fluoride phosphate complex (CCP-ACFP), (b) 0.01 to 10 % by weight of the sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of the viscosity regulator, (e) 0.01 to 5.0 % by weight of the fluoride compound, and (d) a residual amount of water, and being used by applying on a tooth.
- CCP-ACP casein phosphopeptide-amorphous calcium phosphate complex
- CCP-ACFP casein phosphopeptide-amorphous calcium fluoride phosphate complex
- the fluoride compound is at least one selected from the group consisting of sodium fluoride, stannous fluoride, sodium monofluoro phosphate in the composition for oral cavity to prevent a caries according to the second aspect of the present invention.
- the casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) are not especially limited, if it is approved as foods or in dentistry.
- the material prepared by the method of mixing calcium, an inorganic phosphoric acid, and fluoride if necessary with phosphopeptide, filtrating the mixed material, and drying, is preferably used in respect of the composition and crystallinity (refer to published Japanese translation of PTC international publication for patent application 2002-500626).
- the blending amount of the casein phosphopeptide - amorphous calcium phosphate complex (CPP-ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) (a) is 1 to 30 % by weight of the whole composition, preferably 1 to 10 % by weight especially. If said amount is less than 1 % by weight, the supplying of calcium and phosphorus is not sufficient, so that the prevention effect of the caries can not be obtained. If said amount exceeds 30 % by weight, the viscosity of the composition becomes too high.
- the etherification degree of the sodium carboxymethylcellulose (b), which is blended to obtain stability in keeping for a long time, is 0.7 to 1.0, preferably 0.85 to 0.95 especially. Because, if the etherification degree is less than 0.7, the blending effect can not be obtained, and if said amount exceeds 1.0, the sodium carboxymethylcellulose is easily influenced by calcium existing in the CPP - ACP and / or the CPP - ACFP, so that the preservation property becomes to be insufficient, since an insoluble precipitate is generated or said sodium carboxymethylcellulose is gelled.
- the blending amount of the sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0 is 0.01 to 10 % by weight of the whole composition, preferably 1 to 5 % by weight especially. If said amount is less than 0.01 % by weight, the viscosity of the composition is low and it easily flows with saliva at the time of the applying on the tooth. Therefore, the prevention effect of the caries can not be obtained. If said amount exceeds 10 % by weight, the viscosity of the composition is high and it can not easily spread at the time of the applying on the tooth, and the sense of use is also bad.
- composition for the caries prevention of the present invention it is necessary to use (c) the viscosity regulator, in order to use the composition by applying on the tooth and to obtain the prevention effect of the caries by (a) the casein phosphopeptide - amorphous calcium phosphate complex (CPP-ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) being stayed in the oral cavity.
- CPP-ACP casein phosphopeptide - amorphous calcium phosphate complex
- CPP - ACFP casein phosphopeptide - amorphous calcium fluoride phosphate complex
- the viscosity regulator for example, a natural material, such as gum guaiac, carob bean gum, Tara gum, tamarind seed gum, gum arabic, tragacanth gum, karaya gum, carrageenan, xanthan gum, gellan gum, curdlan, chitin, chitosan or chitosamine, an organic synthetic material, such as glycerin, propylene glycol, sodium alginate, propylene glycol ester alginate, sodium starch glycolate, sodium starch phosphate ester, sodium polyacrylate or polyvinyl pyrrolidone, or an inorganic synthetic material, such as calcium carbonate, calcium silicate, a silica fine powder, amorphous hydrous silica or hydrophobic silica, can be used.
- a natural material such as gum guaiac, carob bean gum, Tara gum, tamarind seed gum, gum arabic, tragacanth gum, karaya gum, car
- the viscosity of the composition is suitably 1,000 to 500,000 cP at 25 degree C, preferably 20,000 to 200,000 cP. Therefore, the blending amount of (c) the viscosity regulator is 0.5 to 40 % by weight of the whole composition, preferably 1 to 10 % by weight especially.
- the present invention is of the composition for the oral cavity to prevent the caries, further comprising (e) 0.01 to 5.0 % by weight of a fluoride complex, in order to obtain more caries prevention. If said amount is less than 0.05 % by weight, the acceleration of remineralization is low and if said amount exceeds 5.0 % by weight, the safety to human body becomes low. Preferable amount is 0.05 to 2.0 % by weight.
- the fluoride complex is preferably used at least one selected from the group consisting of sodium fluoride, stannous fluoride, sodium monofluoro phosphate.
- pH is adjusted in the range of 5.5 to 9.5 preferably.
- the method for keeping said range is not limited especially, for example, an aqueous solution of phosphate, which is one of the constitution components of the CPP - ACP and the CPP - ACFP, or phosphate salt is added to adjust the pH preferably.
- composition for the caries prevention of the present invention a sweetener, a colorant, a preservative, an antifungal agent, or a flavor etc., which are used to the general composition for the caries prevention, can be suitably blended.
- compositions for the oral cavity to prevent the caries which were blended with the composition shown in Table 1 and 2, were kept under the conditions at 60 degree C for 1 week, and then, said compositions were observed. These results were collectively shown in Table 3 and 4.
- composition for the caries prevention blended with the composition shown in Table 1 and 2 is coated on the whole surface of the tooth by a tooth brush. After one hour, the calcium ion in the saliva was measured to evaluate the staying ability. These results were shown in Table 3 and 4.
- composition for the caries prevention being excellent in the caries prevention and the stability in keeping for a long time, could be obtained, by selecting the specific sodium carboxymethylcellulose having the specific etherification degree and blending said sodium carboxymethylcellulose with the composition for the caries prevention containing the CPP - ACP and / or CPP-ACFP.
- composition for the caries prevention of the present invention contains the CPP - ACP and / or CPP-ACFP and is blended with sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0, so that it has promoting effect of the remineralization and excellent stability in keeping for a long time. Therefore, said composition has the great value for contributing to dental medicine.
- compositions which are further containing the fluoride complex are excellent in the caries prevention as compared with the compositions which have no fluoride complex as in Examples 1 to 10.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Dental Preparations (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
- The present invention relates to a composition for oral cavity to prevent a caries, which has effects for suppressing tooth demineralization and promoting tooth remineralization.
- Conventionally, as a component for the caries prevention, casein phosphopeptide - amorphous calcium phosphate complex (hereinafter, it is referred to as CPP - ACP) has been known. The CPP - ACP is a material comprising a complex of peptide derived from milk protein (casein) and an inorganic material (an amorphous calcium phosphate) , and it has been said that the CPP - ACP act on demineralization and remineralization of the tooth since it contains calcium and phosphorus, which are inorganic components of the tooth, as the constituent elements (for example, refer to non-patent literature 1, Reynolds EC et al. "Anticariogenicity of calcium phosphate complexes of tryptic casein phosphopeptides in the rat" J Dent Res. 1995 Jun : 74(6) : 1272-9, and non-patent literature 2, Reynolds EC "Remineralization of enamel subsurface lesions by casein phosphopeptide - stabilized calcium phosphate solutions" J Dent Res. 1997 Sep : 76 (9) : 1587-95.)
- As for the caries prevention with the CPP - ACP, two processes comprising an acceleration of remineralization action and an inhibition of demineralization action are considered. The acceleration of remineralization action can be explained by the results, where the concentrations of calcium and phosphorus can be continuously increased and kept in the inside of a demineralized lesion under the enamel subsurface, by continuously supplying the CPP - ACP. Furthermore, the inhibition of demineralization action is based on the following logic, where the solubility of calcium phosphate in the enamel subsurface is remarkably decreased since the ion concentration in saliva on the enamel subsurface or the inside of a dental plaque is kept in the supersaturated state with the ions of calcium and phosphorus came from the CPP - ACP, and then, the tooth becomes to be hardly melted.
- Moreover, it has been known that fluorides have many effects for promoting the remineralization, improving an acid resistance of tooth structure, and suppressing an acid production with exhibiting antimicrobial property to plaque bacteria, and thus a casein phosphopeptide - amorphous calcium fluoride phosphate complex (hereinafter it is referred to as CPP - ACFP), which contains fluorides, has also effect for the caries prevention.
- The foods, such as a chewing gum and a candy, and the compositions for oral care, such as a dentifrice and a mouth washing agent, which assist the caries prevention by containing the CPP - ACP and CPP - ACFP having the above action, have been disclosed (for example, refer to patent literature 1, published Japanese translation of PCT international publication for patent application 2002- 500626, and patent literature 2, published Japanese translation of PCT international publication for patent application 2002- 540129).
- However, in order to demonstrate the preventing effect of the caries with the CPP - ACP in the oral cavity, it is necessary to keep the component of the CPP - ACP for a long time. For example, in the case of the chewing gum blended with the CPP - ACP, it is necessary to chew simultaneously two grains of it, i.e., 3 grams, for 20 minutes and four times per day during two weeks as a standard (refer to non-patent literature 3, Shen P et al. "Remineralization of enamel subsurface lesions by sugar-free chewing gum containing casein phophopeptide - amorphous calcium phosphate." J Dent Res 2001 Dec : 80(12) : 2066-70).
- It is difficult to apply such action many times per day as mentioned above when considering the general lifestyle. So, in order to demonstrate the prevention effect of the caries with the CPP - ACP even when applying 1 time per day, it has been examined to apply the composition for caring the oral cavity like a paste or a cream, which contains the CPP - ACP, on the tooth.
- However, as for the conventional composition for caring the oral cavity like the paste or the cream, which contains the CPP - ACP, there is a problem that the state of the composition becomes uneven since the composition is gelled or lumps are generated at the time of preserving for a long time.
- Then, the present invention has the object to provide the composition for the caries prevention, which has the effects for efficiently suppressing the demineralization and promoting the remineralization, and an excellent stability in keeping for a long time.
- The present inventors made wholeheartedly investigations in order to solve the above problems, and as the result, they found out the method to obtain the excellent composition for the caries prevention. That is, in the composition comprising (a) the casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP), (b) a sodium carboxymethylcellulose, (c) a viscosity regulator, and (d) water, when the sodium carboxymethylcellulose having a specific etherification degree was used, the composition for the caries prevention, which has the effects for efficiently suppressing the demineralization and promoting the remineralization, and the excellent stability in keeping for a long time, was obtained. Then, the present invention was completed.
- In a first aspect of the present invention, composition for the oral cavity to prevent the caries comprises (a) 1 to 30 % by weight of the casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP), (b) 0.01 to 10 % by weight of the sodium carboxymethylcellulose, having the etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of the viscosity regulator, and (d) a residual amount of water. This composition is used by coating on the tooth. In a second aspect of the present invention, a composition for oral cavity to prevent a caries comprises (a) 1 to 30 % by weight of the casein phosphopeptide-amorphous calcium phosphate complex (CCP-ACP) and/or the casein phosphopeptide-amorphous calcium fluoride phosphate complex (CCP-ACFP), (b) 0.01 to 10 % by weight of the sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of the viscosity regulator, (e) 0.01 to 5.0 % by weight of the fluoride compound, and (d) a residual amount of water, and being used by applying on a tooth. In a third aspect of the present invention, the fluoride compound is at least one selected from the group consisting of sodium fluoride, stannous fluoride, sodium monofluoro phosphate in the composition for oral cavity to prevent a caries according to the second aspect of the present invention.
- Hereinafter, the composition for the caries prevention of the present invention will be explained. (a) The casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) are not especially limited, if it is approved as foods or in dentistry. For example, the material prepared by the method of mixing calcium, an inorganic phosphoric acid, and fluoride if necessary with phosphopeptide, filtrating the mixed material, and drying, is preferably used in respect of the composition and crystallinity (refer to published Japanese translation of PTC international publication for patent application 2002-500626).
- At this time, the blending amount of the casein phosphopeptide - amorphous calcium phosphate complex (CPP-ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) (a) is 1 to 30 % by weight of the whole composition, preferably 1 to 10 % by weight especially. If said amount is less than 1 % by weight, the supplying of calcium and phosphorus is not sufficient, so that the prevention effect of the caries can not be obtained. If said amount exceeds 30 % by weight, the viscosity of the composition becomes too high.
- The etherification degree of the sodium carboxymethylcellulose (b), which is blended to obtain stability in keeping for a long time, is 0.7 to 1.0, preferably 0.85 to 0.95 especially. Because, if the etherification degree is less than 0.7, the blending effect can not be obtained, and if said amount exceeds 1.0, the sodium carboxymethylcellulose is easily influenced by calcium existing in the CPP - ACP and / or the CPP - ACFP, so that the preservation property becomes to be insufficient, since an insoluble precipitate is generated or said sodium carboxymethylcellulose is gelled.
- The blending amount of the sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0 is 0.01 to 10 % by weight of the whole composition, preferably 1 to 5 % by weight especially. If said amount is less than 0.01 % by weight, the viscosity of the composition is low and it easily flows with saliva at the time of the applying on the tooth. Therefore, the prevention effect of the caries can not be obtained. If said amount exceeds 10 % by weight, the viscosity of the composition is high and it can not easily spread at the time of the applying on the tooth, and the sense of use is also bad.
- In the composition for the caries prevention of the present invention, it is necessary to use (c) the viscosity regulator, in order to use the composition by applying on the tooth and to obtain the prevention effect of the caries by (a) the casein phosphopeptide - amorphous calcium phosphate complex (CPP-ACP) and / or the casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP) being stayed in the oral cavity. As for (c) the viscosity regulator, for example, a natural material, such as gum guaiac, carob bean gum, Tara gum, tamarind seed gum, gum arabic, tragacanth gum, karaya gum, carrageenan, xanthan gum, gellan gum, curdlan, chitin, chitosan or chitosamine, an organic synthetic material, such as glycerin, propylene glycol, sodium alginate, propylene glycol ester alginate, sodium starch glycolate, sodium starch phosphate ester, sodium polyacrylate or polyvinyl pyrrolidone, or an inorganic synthetic material, such as calcium carbonate, calcium silicate, a silica fine powder, amorphous hydrous silica or hydrophobic silica, can be used.
- When the using method of directly applying on the tooth is considered, the viscosity of the composition is suitably 1,000 to 500,000 cP at 25 degree C, preferably 20,000 to 200,000 cP. Therefore, the blending amount of (c) the viscosity regulator is 0.5 to 40 % by weight of the whole composition, preferably 1 to 10 % by weight especially.
- The present invention is of the composition for the oral cavity to prevent the caries, further comprising (e) 0.01 to 5.0 % by weight of a fluoride complex, in order to obtain more caries prevention. If said amount is less than 0.05 % by weight, the acceleration of remineralization is low and if said amount exceeds 5.0 % by weight, the safety to human body becomes low. Preferable amount is 0.05 to 2.0 % by weight. The fluoride complex is preferably used at least one selected from the group consisting of sodium fluoride, stannous fluoride, sodium monofluoro phosphate.
- Since the composition for the caries prevention of the present invention is directly coated on the tooth, pH is adjusted in the range of 5.5 to 9.5 preferably. Although the method for keeping said range is not limited especially, for example, an aqueous solution of phosphate, which is one of the constitution components of the CPP - ACP and the CPP - ACFP, or phosphate salt is added to adjust the pH preferably.
- In addition, in the composition for the caries prevention of the present invention, a sweetener, a colorant, a preservative, an antifungal agent, or a flavor etc., which are used to the general composition for the caries prevention, can be suitably blended.
- Hereinafter, the present invention will be explained concretely with the examples and comparison examples, but is not limited to the following examples.
- The blends of the compositions used in the examples and the comparison examples were collectively shown in Table 1 and 2, and the pH and the viscosity at 25 degree C of these compositions were collectively shown in Table 3 and 4.
- The compositions for the oral cavity to prevent the caries, which were blended with the composition shown in Table 1 and 2, were kept under the conditions at 60 degree C for 1 week, and then, said compositions were observed. These results were collectively shown in Table 3 and 4.
- The evaluation was carried out by using a bovine tooth in vitro, according to the method described in Reynolds EC "Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions." J. Dent. Res. 1997 Sep; 76(9): 1587-95.
- (1) The bovine tooth was embedded with a dental resin to make an enamel testing surface having the length of 7 mm and the width of 1 mm. Said enamel testing surface was made into an enamel block.
- (2) The enamel block was dipped in 40 ml of the
demineralization liquid, which was blended with
following materials, under an atmosphere at 37 degree
C for 4 days, to make an artificial caries.
Blending of the demineralization liquid (pH 4.8) lactic acid : 0.1 mol / L
calcium chloride : 1.5m.mol/ L
potassium dihydrogen phosphate : 0.9m.mol / L
sodium carboxymethylcellulose (cellogen HE-1500F, made by Daiichi Kogyo Seiyaku Co., Ltd.) : 1% by weight - (3) An enamel varnish was coated on about a half of the enamel block surface, where the artificial caries was made, for not generating the remineralization, and said enamel block was dipped in a slurry liquid, which was obtained by diluting the compositions of Examples 1~20 and Comparison examples 1~4 with distilled water 5 times, for 10 days, to carry out the remineralization treatment. At the Examples 18, 19 and 20, a phosphatase (Phosphatase, acid derived from wheat, made by SIGMA Chem. Co., Ltd.) is added 0.025 units/mL to said slurry liquid.
- (4) A thin sliced piece having the thickness of about 100µm was made from the enamel block.
- (5) A X-ray picture of the thin sliced piece of (4) was photographed, and mineral qualities of demineralized and remineralized parts were calculated with the distances from the surface and the luminances at said parts, by using an image analyzer. Then, a remineralization ratio was obtained. If the value of said ratio was larger, such part was more remineralized. These results were collectively shown in Table 3 and 4.
-
-
- Clearly from Table 3, it was identified that the composition for the caries prevention being excellent in the caries prevention and the stability in keeping for a long time, could be obtained, by selecting the specific sodium carboxymethylcellulose having the specific etherification degree and blending said sodium carboxymethylcellulose with the composition for the caries prevention containing the CPP - ACP and / or CPP-ACFP.
- The composition for the caries prevention of the present invention contains the CPP - ACP and / or CPP-ACFP and is blended with sodium carboxymethylcellulose having the etherification degree of 0.7 to 1.0, so that it has promoting effect of the remineralization and excellent stability in keeping for a long time. Therefore, said composition has the great value for contributing to dental medicine.
- Clearly from Table 4, the compositions which are further containing the fluoride complex, are excellent in the caries prevention as compared with the compositions which have no fluoride complex as in Examples 1 to 10.
Claims (3)
- A composition for oral cavity to prevent a caries, comprising (a) 1 to 30 % by weight of a casein phosphopeptide - amorphous calcium phosphate complex (CPP - ACP) and / or a casein phosphopeptide - amorphous calcium fluoride phosphate complex (CPP - ACFP), (b) 0.01 to 10 % by weight of a sodium carboxymethylcellulose having an etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of a viscosity regulator, and (d) a residual amount of water, and being used by applying on a tooth.
- A composition for oral cavity to prevent a caries, comprising (a) 1 to 30 % by weight of a casein phosphopeptide-amorphous calcium phosphate complex (CPP -ACP) and/or a casein phosphopeptide-amorphous calcium fluoride phosphate complex (CPP-ACFP), (b) 0.01 to 10 % by weight of a sodium carboxymethylcellulose having an etherification degree of 0.7 to 1.0, (c) 0.5 to 40 % by weight of a viscosity regulator, (e) 0.01 to 5.0 % by weight of a fluoride compound, and (d) a residual amount of water, and being used by applying on a tooth.
- A composition for oral cavity to prevent a caries as claimed in Claim 2, wherein the fluoride compound is at least one selected from the group consisting of sodium fluoride, stannous fluoride, sodium monofluoro phosphate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003363014 | 2003-10-23 | ||
JP2003363014 | 2003-10-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1525878A1 true EP1525878A1 (en) | 2005-04-27 |
EP1525878B1 EP1525878B1 (en) | 2007-03-07 |
Family
ID=34386519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04024388A Expired - Lifetime EP1525878B1 (en) | 2003-10-23 | 2004-10-13 | Composition for caries prevention |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050089481A1 (en) |
EP (1) | EP1525878B1 (en) |
AT (1) | ATE355818T1 (en) |
AU (1) | AU2004220761B2 (en) |
CA (1) | CA2485836A1 (en) |
DE (1) | DE602004005123T2 (en) |
NZ (1) | NZ535941A (en) |
SG (1) | SG111252A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1736135A1 (en) * | 2005-06-22 | 2006-12-27 | McNeil-PPC, Inc. | Oral care compositions, devices, and methods of using the same |
WO2007068062A1 (en) * | 2005-12-16 | 2007-06-21 | David Kannar | Surface active calcium phosphates |
WO2007090242A1 (en) * | 2006-02-09 | 2007-08-16 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
US8603988B2 (en) | 2005-06-24 | 2013-12-10 | The University Of Melbourne | Ionic complexes |
US8609071B2 (en) | 2004-11-25 | 2013-12-17 | The University Of Melbourne | Stabilized calcium phosphate complexes |
US8673363B2 (en) | 2005-06-07 | 2014-03-18 | The University Of Melbourne | Dental mineralization |
WO2015095932A1 (en) | 2013-12-24 | 2015-07-02 | The University Of Melbourne | Stabilized stannous compositions |
US10695370B2 (en) | 2013-07-23 | 2020-06-30 | The University Of Melbourne | Compositions and methods for dental mineralization |
CN113766904A (en) * | 2019-03-13 | 2021-12-07 | 墨尔本大学 | Compositions and methods for promoting mineralization |
CN113811278A (en) * | 2019-03-13 | 2021-12-17 | 墨尔本大学 | Concealment of hypomineralised lesions |
US11717536B2 (en) | 2017-03-14 | 2023-08-08 | The University Of Melbourne | Treatment for periodontitis |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0620517A2 (en) * | 2005-11-30 | 2011-11-16 | Unilever Nv | food product, calcium-containing additive and process for the preparation of the food product |
AU2007235359B2 (en) * | 2006-04-05 | 2011-03-10 | Intercontinental Great Brands Llc | Calcium phosphate complex and salts in oral delivery systems |
AU2007235360B2 (en) * | 2006-04-05 | 2010-11-25 | Intercontinental Great Brands Llc | Impact of calcium phosphate complex on dental caries |
US20070237855A1 (en) * | 2006-04-05 | 2007-10-11 | Cadbury Adams Usa Llc | Calcium phosphate complex in acid containing confectionery |
US8741268B2 (en) * | 2009-09-10 | 2014-06-03 | Preventive Technologies, Inc. | Dental prophylactic paste |
JP2011073983A (en) * | 2009-09-29 | 2011-04-14 | Gc Corp | Tooth coating composition |
CN105307624B (en) | 2013-06-18 | 2019-12-31 | 株式会社Lg生活健康 | Oral composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040406A1 (en) * | 1997-03-13 | 1998-09-17 | The University Of Melbourne | Calcium phosphopeptide complexes |
US20030124066A1 (en) * | 2002-01-03 | 2003-07-03 | Cloyd Dixon | Stable oral compositions comprising casein phosphopeptide complexes and fluoride |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3939261A (en) * | 1974-08-30 | 1976-02-17 | Colgate-Palmolive Company | Flavored dentifrice |
JPS5788112A (en) * | 1980-11-20 | 1982-06-01 | Lion Corp | Tooth-paste composition |
MY114945A (en) * | 1997-04-24 | 2003-02-28 | Sunstar Inc | Oral composition |
GB0027405D0 (en) * | 2000-11-09 | 2000-12-27 | S P A | Composition |
MXPA04006541A (en) * | 2002-01-03 | 2004-10-04 | Procter & Gamble | Stable oral compositions comprising casein phosphopeptide complexes and fluoride. |
-
2004
- 2004-10-05 US US10/957,829 patent/US20050089481A1/en not_active Abandoned
- 2004-10-13 DE DE602004005123T patent/DE602004005123T2/en not_active Expired - Lifetime
- 2004-10-13 AT AT04024388T patent/ATE355818T1/en not_active IP Right Cessation
- 2004-10-13 EP EP04024388A patent/EP1525878B1/en not_active Expired - Lifetime
- 2004-10-14 NZ NZ535941A patent/NZ535941A/en unknown
- 2004-10-15 AU AU2004220761A patent/AU2004220761B2/en not_active Expired
- 2004-10-21 CA CA002485836A patent/CA2485836A1/en not_active Abandoned
- 2004-10-22 SG SG200406184A patent/SG111252A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040406A1 (en) * | 1997-03-13 | 1998-09-17 | The University Of Melbourne | Calcium phosphopeptide complexes |
US20030124066A1 (en) * | 2002-01-03 | 2003-07-03 | Cloyd Dixon | Stable oral compositions comprising casein phosphopeptide complexes and fluoride |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9814662B2 (en) | 2004-11-25 | 2017-11-14 | The University Of Melbourne | Stabilized calcium phosphate complexes |
US8609071B2 (en) | 2004-11-25 | 2013-12-17 | The University Of Melbourne | Stabilized calcium phosphate complexes |
US9295628B2 (en) | 2004-11-25 | 2016-03-29 | The University Of Melbourne | Stabilized calcium phosphate complexes |
US8673363B2 (en) | 2005-06-07 | 2014-03-18 | The University Of Melbourne | Dental mineralization |
EP1736135A1 (en) * | 2005-06-22 | 2006-12-27 | McNeil-PPC, Inc. | Oral care compositions, devices, and methods of using the same |
US9241883B2 (en) | 2005-06-24 | 2016-01-26 | The University Of Melbourne | Ionic complexes |
US8603988B2 (en) | 2005-06-24 | 2013-12-10 | The University Of Melbourne | Ionic complexes |
WO2007068062A1 (en) * | 2005-12-16 | 2007-06-21 | David Kannar | Surface active calcium phosphates |
CN102358746A (en) * | 2005-12-16 | 2012-02-22 | 戴维·坎纳尔 | Surface active calcium phosphates |
US9668945B2 (en) | 2006-02-09 | 2017-06-06 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
US11504305B2 (en) | 2006-02-09 | 2022-11-22 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
EP2705826A1 (en) * | 2006-02-09 | 2014-03-12 | The University of Melbourne | Fluoride composition and methods for dental mineralization |
AU2007214265B2 (en) * | 2006-02-09 | 2012-06-14 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
WO2007090242A1 (en) * | 2006-02-09 | 2007-08-16 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
US10695370B2 (en) | 2013-07-23 | 2020-06-30 | The University Of Melbourne | Compositions and methods for dental mineralization |
US11351193B2 (en) | 2013-07-23 | 2022-06-07 | The University Of Melbourne | Compositions and methods for dental mineralization |
US11717537B2 (en) | 2013-07-23 | 2023-08-08 | The University Of Melbourne | Compositions and methods for dental mineralization |
EP3086751A4 (en) * | 2013-12-24 | 2017-08-16 | The University Of Melbourne | Stabilized stannous compositions |
AU2014373625B2 (en) * | 2013-12-24 | 2018-07-19 | The University Of Melbourne | Stabilized stannous compositions |
RU2716134C2 (en) * | 2013-12-24 | 2020-03-06 | Де Юниверсити Оф Мельбурн | Stabilized compositions based on tin (ii) |
US10912722B2 (en) | 2013-12-24 | 2021-02-09 | The University Of Melbourne | Stabilized stannous compositions |
WO2015095932A1 (en) | 2013-12-24 | 2015-07-02 | The University Of Melbourne | Stabilized stannous compositions |
US11564873B2 (en) | 2013-12-24 | 2023-01-31 | The University Of Melbourne | Stabilized stannous compositions |
US11717536B2 (en) | 2017-03-14 | 2023-08-08 | The University Of Melbourne | Treatment for periodontitis |
CN113766904A (en) * | 2019-03-13 | 2021-12-07 | 墨尔本大学 | Compositions and methods for promoting mineralization |
CN113811278A (en) * | 2019-03-13 | 2021-12-17 | 墨尔本大学 | Concealment of hypomineralised lesions |
Also Published As
Publication number | Publication date |
---|---|
SG111252A1 (en) | 2005-05-30 |
AU2004220761B2 (en) | 2009-12-17 |
ATE355818T1 (en) | 2007-03-15 |
EP1525878B1 (en) | 2007-03-07 |
US20050089481A1 (en) | 2005-04-28 |
DE602004005123D1 (en) | 2007-04-19 |
CA2485836A1 (en) | 2005-04-23 |
AU2004220761A1 (en) | 2005-05-12 |
DE602004005123T2 (en) | 2007-11-15 |
NZ535941A (en) | 2006-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1525878B1 (en) | Composition for caries prevention | |
JP6101712B2 (en) | Multi-component oral care composition | |
US8257721B2 (en) | Oral care product | |
EP2301513A2 (en) | Tooth coating composition | |
WO2010106668A1 (en) | Tooth surface repairing material | |
US4146606A (en) | Pharmaceutical compositions for dental use | |
JP2005145952A (en) | Caries-preventing composition | |
WO2018168997A1 (en) | Oral composition capable of promoting teeth remineralization | |
JP5501346B2 (en) | Method for producing tooth mineralizer | |
CN107106428A (en) | Phosphoric acid zinc complex | |
EP3031442B1 (en) | Dentinal tubule sealing material | |
CN107205891A (en) | Personal care composition with trbasic zinc phosphate active matter | |
JP3556849B2 (en) | Oral composition | |
JP2001172147A (en) | Preparation for oral cavity | |
US9205036B2 (en) | Dental composition | |
EP3668478A1 (en) | Oral care composition | |
CN114681341B (en) | Stable toothpaste capable of removing stains, whitening skin and reducing gingivitis and preparation method thereof | |
JP6035608B2 (en) | Tooth mineralizing agent and method for producing the same | |
US10130561B2 (en) | Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications | |
EP2956112B1 (en) | Dental composition | |
WO2014124950A1 (en) | Novel composition | |
JP2011037779A (en) | Caries-preventing composition | |
CN112891234A (en) | Biphase calcium-phosphorus material and toothpaste containing biphase calcium-phosphorus material | |
US20160317580A9 (en) | Composition and method for dental remineralization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK |
|
17P | Request for examination filed |
Effective date: 20050602 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/21 20060101AFI20070130BHEP Ipc: A61K 8/64 20060101ALI20070130BHEP Ipc: A61K 8/73 20060101ALI20070130BHEP Ipc: A61Q 11/00 20060101ALI20070130BHEP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 602004005123 Country of ref document: DE Date of ref document: 20070419 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070618 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070807 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EN | Fr: translation not filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
26N | No opposition filed |
Effective date: 20071210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071026 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071015 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070607 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071013 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070307 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070908 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230502 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231016 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20231025 Year of fee payment: 20 Ref country code: DE Payment date: 20231016 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20231023 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 602004005123 Country of ref document: DE |